[HTML][HTML] Long-term day-case treatment of peripheral neuromuscular disease with intravenous immunoglobulin: the practice of a regional day-case service in Preston …
J Nixon, C McHugh, S Jones - Clinical medicine, 2013 - ncbi.nlm.nih.gov
Neuromuscular disease is one of the most common indications for the use of intravenous
immuno-globulin (IVIG). We describe practical aspects of IVIG administration and dosing in …
immuno-globulin (IVIG). We describe practical aspects of IVIG administration and dosing in …
Intravenous immune globulin usage for neurological and neuromuscular disorders: an academic centre, 4 years experience
L Sarti, T Falai, F Pinto, E Tendi, S Matą - Neurological sciences, 2009 - Springer
Intravenous immune globulin (IVIg) use for labeled and unlabeled indications has grown in
the last years. Aim of this study was to evaluate the IVIg usage profile for neurological …
the last years. Aim of this study was to evaluate the IVIg usage profile for neurological …
The use of IVIg in the treatment of inflammatory polyneuropathies and myasthenia gravis at The Walton Centre
S Kimyongur, B Hywel, J Holt - Journal of the Royal College …, 2019 - journals.sagepub.com
Background Immunoglobulin is a blood product used in a variety of medical disorders,
usually delivered intravenously (IVIg). Neurology patients, particularly those with …
usually delivered intravenously (IVIg). Neurology patients, particularly those with …
A retrospective analysis of the safety profile of intravenous immunoglobulin in 1176 patients receiving home infusion therapy
N Souayah, A Pahwa, L Burawski, T Opila… - Journal of clinical …, 2018 - journals.lww.com
Objectives: This analysis assessed the safety of intravenous immunoglobulin (IVIg) in the
treatment of patients with neuroimmunological and immunological disorders in a home …
treatment of patients with neuroimmunological and immunological disorders in a home …
Safety of liquid intravenous immunoglobulin for neuroimmunologic disorders in the home setting: a retrospective analysis of 1085 infusions
M Rigas, R Tandan, RJ Sterling - Journal of Clinical …, 2008 - journals.lww.com
Objective: To examine the overall safety of intravenous immunoglobulin (IVIG) administered
according to a clinically defined, home-based therapeutic regimen in patients with …
according to a clinically defined, home-based therapeutic regimen in patients with …
Intravenous immunoglobulin in autoimmune neuromuscular diseases
MC Dalakas - Jama, 2004 - jamanetwork.com
ContextIntravenous immunoglobulin (IVIG) enhances immune homeostasis by modulating
expression and function of Fc receptors, interfering with activation of complement and …
expression and function of Fc receptors, interfering with activation of complement and …
[HTML][HTML] Off-label use of intravenous immunoglobulin for neurological conditions: a review of clinical effectiveness
D Sutton, S Visintini - 2018 - europepmc.org
The purpose of this Rapid Response Report is to collect, critically appraise and evaluate the
current evidence on the clinical effectiveness off-label use of intravenous immunoglobulin …
current evidence on the clinical effectiveness off-label use of intravenous immunoglobulin …
Practical aspects of transitioning from intravenous to subcutaneous immunoglobulin therapy in neuromuscular disorders
D Menon, E Sarpong, V Bril - Canadian Journal of Neurological …, 2022 - cambridge.org
Recent evidence shows that subcutaneous immunoglobulin (SCIG) is as efficacious as
intravenous immunoglobulin (IVIG) and has a better safety profile and acceptance rate …
intravenous immunoglobulin (IVIG) and has a better safety profile and acceptance rate …
The use of intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: evidence-based indications and safety profile
MC Dalakas - Pharmacology & therapeutics, 2004 - Elsevier
Intravenous immunoglobulin (IVIg) has multiple actions on the immunoregulatory network
that operate in concert with each other. For each autoimmune neuromuscular disease …
that operate in concert with each other. For each autoimmune neuromuscular disease …
Home IVIG for CIDP: a focus on patient centred care
HD Katzberg, V Rasutis, V Bril - Canadian Journal of Neurological …, 2013 - cambridge.org
Objective: To determine the safety and tolerability of home-based intravenous
immunoglobulin (IVIG)(Gamunex) as maintenance treatment in patients with chronic …
immunoglobulin (IVIG)(Gamunex) as maintenance treatment in patients with chronic …
Related searches
- safety profile intravenous immunoglobulin
- clinical audit intravenous immunoglobulin
- neurological conditions intravenous immunoglobulin
- retrospective analysis intravenous immunoglobulin
- neuromuscular disorders practical aspects
- immunoglobulin therapy practical aspects
- neuromuscular disorders immunoglobulin therapy
- clinical effectiveness intravenous immunoglobulin